1. Home
  2. CMU vs TIL Comparison

CMU vs TIL Comparison

Compare CMU & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Municipal Income Trust

CMU

MFS Municipal Income Trust

HOLD

Current Price

$3.48

Market Cap

88.5M

Sector

Finance

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$10.74

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMU
TIL
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.5M
177.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CMU
TIL
Price
$3.48
$10.74
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$100.67
AVG Volume (30 Days)
82.4K
72.7K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
4.08%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$10.70
52 Week High
$3.38
$42.79

Technical Indicators

Market Signals
Indicator
CMU
TIL
Relative Strength Index (RSI) 46.72 36.08
Support Level $3.46 $10.76
Resistance Level $3.53 $11.51
Average True Range (ATR) 0.02 0.73
MACD -0.00 0.16
Stochastic Oscillator 28.57 2.71

Price Performance

Historical Comparison
CMU
TIL

About CMU MFS Municipal Income Trust

Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: